Cargando…

May 2021: Heterogeneity in reported skin manifestations of COVID-19 and vaccines

Detalles Bibliográficos
Autor principal:	Kantor, Jonathan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	by the American Academy of Dermatology, Inc. 2021
Materias:	This month in JAAD International
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997560/ https://www.ncbi.nlm.nih.gov/pubmed/33775460 http://dx.doi.org/10.1016/j.jaad.2021.03.022

Ejemplares similares

This month in JAAD International: November 2021: COVID-19 and hair loss
por: Kantor, Jonathan
Publicado: (2021)

This month in JAAD International: March 2022: Photography, skin cancer, and the limits of teledermatology during the COVID-19 pandemic
por: Kantor, Jonathan
Publicado: (2022)

This Month in JAAD International: August 2022: Cutaneous reactions to COVID-19 messenger RNA booster dose vaccination
por: Kantor, Jonathan
Publicado: (2022)

This Month in JAAD: May 2021
por: Elston, Dirk
Publicado: (2021)

This Month in JAAD International: October 2022: Vaccine hesitancy and medical specialists
por: Kantor, Jonathan
Publicado: (2022)

This Month in JAAD: July 2021
por: Elston, Dirk M.
Publicado: (2021)

January 2021: Skin of color images
por: Sloan, Brett
Publicado: (2021)

July 2021: Lisinopril for delayed inflammatory responses to hyaluronic acid fillers after COVID-19 vaccinations
por: Sloan, Brett
Publicado: (2021)

This Month in JAAD Case Reports: March 2021
por: Sloan, Brett
Publicado: (2021)

Reply to “Varicella-like exanthem as a specific COVID-19–associated skin manifestation: multicenter case series of 22 patients”: Discussing specificity
por: Ortega-Quijano, Daniel, et al.
Publicado: (2020)

Skin reactions to COVID-19 vaccines: An American Academy of Dermatology/International League of Dermatological Societies registry update on reaction location and COVID vaccine type
por: Freeman, Esther E., et al.
Publicado: (2022)

Cutaneous manifestations in COVID-19: Lessons learned from current evidence
por: Suchonwanit, Poonkiat, et al.
Publicado: (2020)

Reply to: “A dermatologic manifestation of COVID-19: Transient livedo reticularis”
por: Thomas, Cristina
Publicado: (2020)

Reply to: “Reply: A dermatologic manifestation of COVID-19: Transient livedo reticularis”
por: Manalo, Iviensan F., et al.
Publicado: (2020)

Preliminary outcomes of 2020-2021 dermatology residency application cycle and adverse effects of COVID-19
por: Thatiparthi, Akshitha, et al.
Publicado: (2021)

Reply to “Varicella-like exanthem as a specific COVID-19-associated skin manifestation: Multicenter case series of 22 patients”: To consider varicella-like exanthem associated with COVID-19, virus varicella zoster and virus herpes simplex must be ruled out
por: Llamas-Velasco, Mar, et al.
Publicado: (2020)

Response to: “Reply to ‘Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients’: To consider varicella-like exanthem associated with COVID-19, virus varicella zoster and virus herpes simplex must be ruled out”
por: Marzano, Angelo Valerio, et al.
Publicado: (2020)

The oral cavity cannot be forgotten in the COVID-19 era: Is there a connection between dermatologic and oral manifestations?
por: Bemquerer, Larissa Marques, et al.
Publicado: (2021)

Reply to: “Various forms of skin rash in COVID-19: Petechial rash in a patient with COVID-19 infection”
por: Joob, Beuy, et al.
Publicado: (2020)

Comment on “The spectrum of COVID-19-associated dermatologic manifestations: An international registry of 716 patients from 31 countries”
por: Baab, Kelsey, et al.
Publicado: (2021)

Response to: “Comment on ‘The spectrum of COVID-19-associated dermatologic manifestations: An international registry of 716 patients from 31 countries’”
por: Freeman, Esther E., et al.
Publicado: (2021)

This Month in JAAD Case Reports: March 2022. Reactive infectious mucocutaneous eruption secondary to SARS-CoV-2
por: Sloan, Brett
Publicado: (2022)

Toward a COVID-19 vaccine strategy for patients with pemphigus on rituximab
por: Waldman, Reid A., et al.
Publicado: (2021)

If skin is a potential host of SARS-CoV-2, IL-17 antibody could reduce the risk of COVID-19
por: Xu, Qiannan, et al.
Publicado: (2021)

Characterization of acute acral skin lesions in nonhospitalized patients: A case series of 132 patients during the COVID-19 outbreak
por: Fernandez-Nieto, Diego, et al.
Publicado: (2020)

Dermatologic manifestations of hydroxychloroquine therapy: A closer look at the nails
por: Lipner, Shari R., et al.
Publicado: (2020)

Reply to: “COVID-19 vaccination in IMID patients receiving rituximab: A personalized regimen should be formulated”
por: Pahalyants, Vartan, et al.
Publicado: (2022)

Response to McMahon et al's “Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of four hundred fourteen cases”
por: Poulas, Konstantinos, et al.
Publicado: (2022)

COVID-19 vaccination in patients with immune-mediated inflammatory diseases receiving rituximab: A personalized regimen should be formulated
por: Yang, Qian, et al.
Publicado: (2022)

The underrepresentation of “COVID toes” in skin of color: An example of racial bias or evidence of a tenuous disease association?
por: Cline, Abigail, et al.
Publicado: (2021)

How telemedicine may exacerbate disparities in patients with limited English proficiency
por: Linggonegoro, Danny W., et al.
Publicado: (2021)

Absence of specific cutaneous manifestations of severe acute respiratory syndrome coronavirus 2 in a reference center in Brazil
por: Avancini, Joao, et al.
Publicado: (2021)

Myriad of Mucocutaneous Manifestations in Multisystem Inflammatory Syndrome Associated with COVID-19
por: Prithvi, Ashwini, et al.
Publicado: (2023)

COVID-19 and racial disparities
por: Shah, Monica, et al.
Publicado: (2020)

Caution in the time of rashes and COVID-19
por: Vesely, Matthew D., et al.
Publicado: (2020)

Algorithm for the classification of COVID-19 rashes
por: Ortega-Quijano, Daniel, et al.
Publicado: (2020)

Androgenetic alopecia in COVID-19: Compared to what?
por: Nanes, Benjamin A.
Publicado: (2020)

COVID-19 and immunomodulator/immunosuppressant use in dermatology
por: Price, Kyla N., et al.
Publicado: (2020)

Reply to: “Skin damage among health care workers managing coronavirus disease 2019”
por: Maliyar, Khalad, et al.
Publicado: (2020)

Reply to: “Skin damage among health care workers managing coronavirus disease-2019”
por: Oranges, Teresa, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_a3d4de5sue1q8f375kismmkjdf